ViTToria Biotherapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $3.05M

  • Investors
  • 11

ViTToria Biotherapeutics General Information

Description

Operator of a gene-edited cell therapeutics company intended to deliver next-generation, paradigm-shifting T-cell therapies. The company's technology improves efficacy, enhances safety, and expands the utility of cell-based therapeutics by lowering dosing requirements, easing preconditioning regimens, reducing manufacturing failures, and shortening vein-to-vein times, enabling medical practitioners to improve patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3675 Market Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States
+1 (215)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3675 Market Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States
+1 (215)

ViTToria Biotherapeutics Timeline

202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ViTToria Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 01-Jan-2024 $3.05M Completed Pre-Clinical Trials
3. Seed Round Cancelled Pre-Clinical Trials
2. Seed Round 07-Jun-2022 $10M $10M Completed Pre-Clinical Trials
1. Accelerator/Incubator 08-Feb-2022 Completed Stealth
To view ViTToria Biotherapeutics’s complete valuation and funding history, request access »

ViTToria Biotherapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view ViTToria Biotherapeutics’s complete cap table history, request access »

ViTToria Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a gene-edited cell therapeutics company intended to deliver next-generation, paradigm-shifting T-cell therap
Drug Discovery
Philadelphia, PA
13 As of 2024

South San Francisco, CA
 

Pittsburgh, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ViTToria Biotherapeutics Competitors (42)

One of ViTToria Biotherapeutics’s 42 competitors is Amphivena Therapeutics, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amphivena Therapeutics Venture Capital-Backed South San Francisco, CA
Noveome Biotherapeutics Venture Capital-Backed Pittsburgh, PA
Cidara Therapeutics Formerly VC-backed San Diego, CA
Gyre Therapeutics Formerly VC-backed San Diego, CA
Adimab Venture Capital-Backed Lebanon, NH
You’re viewing 5 of 42 competitors. Get the full list »

ViTToria Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ViTToria Biotherapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ben Franklin Technology Partners of Southeastern Pennsylvania Accelerator/Incubator Minority
BioAdvance Venture Capital Minority
Global BioAccess Fund Venture Capital Minority
Knollwood Investment Fund Venture Capital Minority
Leukemia & Lymphoma Society Not-For-Profit Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

ViTToria Biotherapeutics FAQs

  • When was ViTToria Biotherapeutics founded?

    ViTToria Biotherapeutics was founded in 2021.

  • Where is ViTToria Biotherapeutics headquartered?

    ViTToria Biotherapeutics is headquartered in Philadelphia, PA.

  • What is the size of ViTToria Biotherapeutics?

    ViTToria Biotherapeutics has 13 total employees.

  • What industry is ViTToria Biotherapeutics in?

    ViTToria Biotherapeutics’s primary industry is Drug Discovery.

  • Is ViTToria Biotherapeutics a private or public company?

    ViTToria Biotherapeutics is a Private company.

  • What is ViTToria Biotherapeutics’s current revenue?

    The current revenue for ViTToria Biotherapeutics is .

  • How much funding has ViTToria Biotherapeutics raised over time?

    ViTToria Biotherapeutics has raised $13M.

  • Who are ViTToria Biotherapeutics’s investors?

    Ben Franklin Technology Partners of Southeastern Pennsylvania, BioAdvance, Global BioAccess Fund, Knollwood Investment Fund, and Leukemia & Lymphoma Society are 5 of 11 investors who have invested in ViTToria Biotherapeutics.

  • Who are ViTToria Biotherapeutics’s competitors?

    Amphivena Therapeutics, Noveome Biotherapeutics, Cidara Therapeutics, Gyre Therapeutics, and Adimab are some of the 42 competitors of ViTToria Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »